US Stock MarketDetailed Quotes

LEXX Lexaria Bioscience

Watchlist
  • 2.3400
  • -0.1400-5.65%
Close Dec 11 16:00 ET
40.84MMarket Cap-4.98P/E (TTM)

About Lexaria Bioscience Company

Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.

Company Profile

SymbolLEXX
Company NameLexaria Bioscience
Listing DateJan 12, 2021
Founded2004
CEOMr. Richard C. Christopher
MarketNASDAQ
Employees7
Fiscal Year Ends08-31
Address740 McCurdy Road,Suite 100
CityKelowna
ProvinceBritish Columbia
CountryCanada
Zip CodeV1X 2P7
Phone1-250-765-6424
Websitehttp://www.lexariabioscience.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard C. Christopher
  • Chief Executive Officer
  • 519.32K
  • Michael Elliot Shankman
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • John M. Docherty
  • President, Principal Executive Officer and Director
  • 414.42K
  • Christopher Bunka
  • Chairman of the Board
  • 884.84K
  • Albert L. Reese, Jr
  • Independent Director
  • 74.83K
  • Nicholas W. Baxter
  • Independent Director
  • 74.83K
  • Baljinder Kaur Bhullar
  • Independent Director
  • --
  • William Edward McKechnie
  • Independent Director
  • 69.83K
  • Dr. Catherine C. Turkel
  • Independent Director
  • 74.83K
Heat List
US
Overall
Symbol
Price
% Chg

No Data